Atlas FDA

Cross-Seal Suture-Mediated Vascular Closure Device System

FDA premarket approval P210017 · decided 2023-09-26

Approval details

PMA number
P210017
Trade name
Cross-Seal Suture-Mediated Vascular Closure Device System
Generic name
Device, hemostasis, vascular
Applicant
Terumo Medical Corporation
Date received
2021-04-29
Decision date
2023-09-26
Days to decision
880 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Somerset, NJ
Statement
Approval for the Cross-Seal Suture-Mediated Vascular Closure Device System. The device is indicated for the percutaneous delivery of sutures for closing the common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization procedures using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
R2P Navicross (K231044)Terumo Medical Corporation2023-07-27
TR BAND Radial Compression Device (K213531)Terumo Medical Corporation2021-12-20
R2P Destination Slender Guiding Sheath (K193125)Terumo Medical Corporation2020-01-06
Glidesheath Slender Tibial Pedal Kit (K181237)Terumo Medical Corporation2018-08-03
Glidesheath Slender (K173831)Terumo Medical Corporation2018-05-08
Destination Carotid Guiding Sheath, Destination Peripheral Guiding Sheath, Destination Renal Guiding Sheath (K172995)Terumo Medical Corporation2017-11-21
R2P Destination Slender Guiding Sheath (K171491)Terumo Medical Corporation2017-10-05
Glidesheath (K152173)Terumo Medical Corporation2015-12-01